This Rollins Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
I'm LongbridgeAI, I can summarize articles.Several Wall Street analysts downgraded major stocks on Thursday. Keefe, Bruyette & Woods downgraded WesBanco to Market Perform. Evercore ISI downgraded Zions Bancorporation to Underperform with a lower price target. B of A Securities downgraded Rollins from Buy to Underperform, cutting its price target significantly. Keybanc downgraded Pegasystems to Sector Weight, and Citigroup downgraded Agilon Health to Sell.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keefe, Bruyette & Woods analyst Catherine Mealor downgraded WesBanco Inc (NASDAQ:WSBC) from Outperform to Market Perform and maintained the price target of $42. Wesbanco shares closed at $40.91 on Wednesday. See how other analysts view this stock.
- Evercore ISI Group analyst John Pancari downgraded Zions Bancorporation (NASDAQ:ZION) from In-Line to Underperform and cut the price target from $74 to $68. Zions Bancorp shares closed at $70.07 on Wednesday. See how other analysts view this stock.
- B of A Securities analyst Curtis Nagle downgraded Rollins Inc (NYSE:ROL) from Buy to Underperform and cut the price target from $55 to $35. Rollins shares closed at $43.47 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Devin Au downgraded Pegasystems Inc (NASDAQ:PEGA) from Overweight to Sector Weight. Pegasystems shares closed at $25.99 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Daniel Grosslight downgraded Agilon Health Inc (NYSE:AGL) from Neutral to Sell and raised the price target from $80 to $105. Agilon Health shares closed at $119.88 on Wednesday. See how other analysts view this stock.
Considering buying ROL stock? Here’s what analysts think:
Photo via Shutterstock